Companies similar to SYNDAX PHARMACEUTICALS INC (SNDX)
Health Care · NASDAQ
SYNDAX PHARMACEUTICALS INC (SNDX)'s closest peers include Incyte (INCY), NOVARTIS AG (NVS), Bristol Myers Squibb (BMY), Gilead Sciences (GILD) and AbbVie (ABBV). This peer set is drawn from SNDX's enriched company profile and is informational only — not financial advice.
Similar companies
-
IncyteINCYHealth Care
A biopharmaceutical company pioneering targeted therapies for blood cancers and inflammatory diseases, with flagship JAK inhibitor JAKAFI generating…
$117.39 (as of 2026-07-21) · market cap $23.6B
-
NOVARTIS AGNVS
Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
$153.87 (as of 2026-07-21) · market cap $228.2B
-
Bristol Myers SquibbBMYHealth Care
Bristol Myers Squibb is a leading biopharmaceutical company specializing in advanced oncology, immunology, and cardiovascular therapies using diverse…
$60.93 (as of 2026-07-21) · market cap $123.2B
-
Gilead SciencesGILDHealth Care
A diversified biopharmaceutical company pioneering viral disease treatments, cell therapies, and oncology medicines with a portfolio spanning HIV, hepatitis,…
$130.28 (as of 2026-07-21) · market cap $161.3B
-
AbbVieABBVHealth Care
Global biopharmaceutical company with leadership positions in immunology, neuroscience, oncology, and aesthetics targeting complex diseases.
$256.10 (as of 2026-07-21) · market cap $447.7B
Not quite? Describe exactly what you want →
Peers are drawn from SNDX's enriched profile (the same similarity signal the chat uses for "companies like SNDX"). See the full profile: SYNDAX PHARMACEUTICALS INC (SNDX).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.